Who is happy about the new home HD vs. PD survival study?

We bet that you can guess that NxStage is pretty excited about the terrific 5-year survival outcomes of home HD—especially since nocturnal HD (which is much more like the treatment done in Australia and New Zealand) has finally been approved in the US.

Read the full article » | Posted 07-08-2015

Related Articles

• Fresenius Fleet Management Solution Supports Home Dialysis Growth Posted 02-09-2021
• Outset Medical Analyzed By Investors Posted 01-12-2021
• Quanta Appoints John S. Lipman as President of North America Posted 12-10-2020
• Baxter’s Theranova Dialyzer Debuts Posted 11-12-2020